JPMorgan Chase vs Wells Fargo &
JPM and WFC side by side, both in commercial banks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How JPM and WFC compare
JPMorgan Chase is the larger company, worth 3.6 times as much as Wells Fargo & ($896B against $252B).
On earnings, Wells Fargo & is cheaper: it trades at 12.1× trailing earnings, against 14.4× for JPMorgan Chase.
JPMorgan Chase grew revenue faster over the last twelve months (13.5% versus 6.2% for Wells Fargo &).
JPMorgan Chase keeps more of each dollar of sales as profit, with a net margin of 32.6% compared with 26.0% at Wells Fargo &.
Both pay dividends: JPMorgan Chase yields 1.8% and Wells Fargo & 2.2%.
JPMorgan Chase scores higher on the StockData Score (17 against 11 for Wells Fargo &), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | JPM | WFC |
|---|---|---|
| Size and price | ||
| Market cap | $896B | $252B |
| Share price | $337.04 | $83.40 |
| Change, 1 year | 10.3% | −3.0% |
| Change, 5 years | 101% | 65.3% |
| Beta (5Y) | 1.01 | 0.98 |
| Employees | 319K | 205K |
| StockData Score | ||
| Total score | 17 (better) | 11 |
| Valuation score | 0 | 2 (better) |
| Growth score | 4 (better) | 1 |
| Performance score | 5 (better) | 4 |
| Health score | 5 (better) | 2 |
| Dividend score | 3 (better) | 2 |
| Valuation | ||
| P/E | 14.4× | 12.1× (better) |
| P/S | 4.5× | 2.9× (better) |
| P/B | 2.4× | 1.4× (better) |
| PEG | 0.79 | 0.50 (better) |
| Fair value | $246.53 | $77.51 |
| Margin of safety | −36.7% | −7.6% (better) |
| Growth | ||
| Revenue growth (TTM) | 13.5% (better) | 6.2% |
| Revenue growth, 5Y average | 8.7% (better) | 2.4% |
| Net income growth (TTM) | 15.1% (better) | 9.9% |
| EPS growth (TTM) | 19.8% (better) | 17.8% |
| EPS growth, 5Y average | 17.7% | 70.9% (better) |
| Profitability | ||
| Net margin | 32.6% (better) | 26.0% |
| Return on equity | 17.8% (better) | 12.5% |
| Financial health | ||
| Debt / equity | 0.19 | 0.14 (better) |
| Altman Z-score | 0.28 (better) | 0.26 |
| Piotroski F-score | 3 | 5 (better) |
| Dividends and buybacks | ||
| Dividend yield | 1.8% | 2.2% (better) |
| Payout ratio | 26.6% | 24.7% |
| Years of dividend growth | 15 (better) | 4 |
| Dividend growth, 5Y average | 10.0% (better) | 6.9% |
| Buyback yield | 3.5% | 7.1% (better) |
| Shareholder yield | 5.4% | 9.4% (better) |
| Ownership | ||
| Held by institutions | 74.7% | 77.4% |
| Held by insiders | 0.37% | 0.17% |
| Insider net buying, 12 months | −$126M | −$10.1M (better) |
| Superinvestors holding | 10 (better) | 9 |
Go deeper
- JPM stock overview
- JPM income statement
- JPM valuation and score
- WFC stock overview
- WFC income statement
- WFC valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.